494 related articles for article (PubMed ID: 30127724)
1. Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention.
Ferreira SA; Romero-Ramos M
Front Cell Neurosci; 2018; 12():247. PubMed ID: 30127724
[TBL] [Abstract][Full Text] [Related]
2. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
[TBL] [Abstract][Full Text] [Related]
4. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein Alters Toll-Like Receptor Expression.
Béraud D; Twomey M; Bloom B; Mittereder A; Ton V; Neitzke K; Chasovskikh S; Mhyre TR; Maguire-Zeiss KA
Front Neurosci; 2011; 5():80. PubMed ID: 21747756
[TBL] [Abstract][Full Text] [Related]
6. Immune system responses in Parkinson's disease: Early and dynamic.
Tansey MG; Romero-Ramos M
Eur J Neurosci; 2019 Feb; 49(3):364-383. PubMed ID: 30474172
[TBL] [Abstract][Full Text] [Related]
7. Microglia in Parkinson's Disease.
Ho MS
Adv Exp Med Biol; 2019; 1175():335-353. PubMed ID: 31583594
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.
Christiansen JR; Olesen MN; Otzen DE; Romero-Ramos M; Sanchez-Guajardo V
J Neuroinflammation; 2016 Apr; 13(1):74. PubMed ID: 27055651
[TBL] [Abstract][Full Text] [Related]
9. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
11. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
George S; Brundin P
J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
[TBL] [Abstract][Full Text] [Related]
13. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
[TBL] [Abstract][Full Text] [Related]
14. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
15. Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease.
Su R; Zhou T
Front Aging Neurosci; 2021; 13():769506. PubMed ID: 34803660
[TBL] [Abstract][Full Text] [Related]
16. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
[TBL] [Abstract][Full Text] [Related]
17. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease.
Li Y; Niu M; Zhao A; Kang W; Chen Z; Luo N; Zhou L; Zhu X; Lu L; Liu J
J Neuroinflammation; 2019 Dec; 16(1):263. PubMed ID: 31831012
[TBL] [Abstract][Full Text] [Related]
18. Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson's Disease Risk.
Booms A; Coetzee GA
Front Cell Neurosci; 2021; 15():759571. PubMed ID: 34671245
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Alpha-Synuclein and Immune Cell Function.
Grozdanov V; Danzer KM
Front Cell Dev Biol; 2020; 8():562692. PubMed ID: 33178682
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein and Lewy pathology in Parkinson's disease.
Kalia LV; Kalia SK
Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
